Tuesday, July 7, 2026
ADVT 
National

Ottawa to extend EI sickness benefits

Darpan News Desk The Canadian Press, 25 Nov, 2022 02:00 PM
  • Ottawa to extend EI sickness benefits

OTTAWA - The federal government is extending employment insurance sickness benefits to 26 weeks, up from 15 weeks, Employment Minister Carla Qualtrough announced on Friday.

Workers applying for EI will be eligible for the more-generous benefits starting on Dec. 18, with advocates praising the move but urging the government to make good on its promise for a much bigger overhaul of the system.

Qualtrough made the announcement while visiting the Canadian Cancer Society's regional care centre in Vancouver.

"Far too many workers pay into EI, and yet when they become seriously ill, when they have injuries to recover for, the 15 weeks doesn't cover their injury duration," Qualtrough said.

"We know that. And organizations like yours have been advocating for increasing the number of EI sickness weeks for a very long time."

The maximum length of unpaid medical leave available to federally regulated private-sector workers is also being extended to 27 weeks from 17, starting on the same date.

That change will ensure that such workers can take enough unpaid leave from their jobs to receive the extended EI sickness benefits.

In September, Qualtrough met with labour leaders and promised to extend EI sickness benefits from 15 to 26 weeks by the end of the year, a change that was telegraphed in the 2022 budget.

On Friday, a spokesperson for the National Council of Unemployed Workers called the announcement "a major step forward."

"But this is not a new thing, and this announcement in no way replaces the long-awaited EI reform, which is expected to be introduced in early December," said Pierre Céré in a statement.

In 2021, the Liberals campaigned on a promise to modernize EI and pledged to expand the program to cover self-employed workers and address gaps, including those highlighted by the COVID-19 pandemic.

Employment and Social Development Canada has held a series of public consultations on EI reform that concluded in the summer.

Qualtrough had previously said that the government will present its plan by the end of the year. She added on Friday that the government "will have a lot more to say" about modernization.

MORE National ARTICLES

Fish processing plant to close in Surrey, B.C.

Fish processing plant to close in Surrey, B.C.
Fisheries Minister Joyce Murray could not immediately be reached for comment but said last month she plans to ensure the decision to phase out 19 open-net pen farms from the Discovery Islands is carried on to completion.

Fish processing plant to close in Surrey, B.C.

Copy-cat fear after Texas synagogue hostage siege

Copy-cat fear after Texas synagogue hostage siege
Toronto police have also increased patrols around synagogues and other Jewish community buildings, although they have said there is no known threat at this time.

Copy-cat fear after Texas synagogue hostage siege

Winter storm pummels large stretch of Ontario

Winter storm pummels large stretch of Ontario
Environment Canada issued snowfall, winter storm or blizzard warnings for a stretch of the province spanning from the Cornwall area to the east, the Algonquin region to the west, and the Niagara and London regions to the south.

Winter storm pummels large stretch of Ontario

China Omicron claim on Canada 'ludicrous': expert

China Omicron claim on Canada 'ludicrous': expert
A Chinese state-controlled news outlet first reported that the Jan. 7 infection of a Beijing resident was the result of receiving a letter or parcel from Canada that passed through Hong Kong.

China Omicron claim on Canada 'ludicrous': expert

Health Canada approves Pfizer COVID-19 drug

Health Canada approves Pfizer COVID-19 drug
The agency authorized Paxlovid for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill. Health Canada did not authorize it for use on teenagers or on patients who are already hospitalized because of COVID-19

Health Canada approves Pfizer COVID-19 drug

Pfizer antiviral approved in Canada

Pfizer antiviral approved in Canada
The authorization posted to the Health Canada website Monday morning says the treatment can be used for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill.

Pfizer antiviral approved in Canada